Krka Free to Market Drug in Slovenia, Hungary
Ljubljana, 20 October - The Ljubljana District Court has rejected a motion for a temporary injunction prohibiting the marketing of Krka's drug Prenessa in Slovenia. The same ruling was arrived at for Hungary by a court in Budapest, the pharma company said on Friday.
The rest of this news item is available to subscribers.
The news item consists of 615 characters (without spaces) or 105 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.